Occupational therapy in ankylosing spondylitis: Short-term prospective study in patients treated with anti-TNF-alpha drugs

Joint Bone Spine

Volumn 75, Issue 1, 2008, Pages 29-33

  Spadaro, Antonio ^a   De Luca, Tania ^a   Massimiani, Maria Pia ^a   Ceccarelli, Fulvia ^a   Riccieri, Valeria ^a   Valesini, Guido ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Ankylosing spondylitis; Anti TNF alpha drugs; Occupational therapy

Indexed keywords

C REACTIVE PROTEIN; ETANERCEPT; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ANKYLOSING SPONDYLITIS; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; EXERCISE; FEMALE; HUMAN; JOINT MOBILITY; MALE; OCCUPATIONAL THERAPY; PAIN; SCORING SYSTEM; SYMPTOMATOLOGY;

ADULT; ANTIBODIES, MONOCLONAL; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; COMBINED MODALITY THERAPY; FEMALE; HEALTH STATUS INDICATORS; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; OCCUPATIONAL THERAPY; PROSPECTIVE STUDIES; RECEPTORS, TUMOR NECROSIS FACTOR; RECOVERY OF FUNCTION; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 37749041942     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2007.07.006     Document Type: Article

References (23)

1. Khan M. Ankylosing spondylitis. In: Klippel J.H., and Dieppe P.A. (Eds). Rheumatology. 2nd ed. (1998), Mosby, London
2. Ryall N.H., and Helliwell P. A critical review of ankylosing spondylitis. Phys Rehabil Med 10 (1998) 265-301
3. Lee H.S., Kim T.H., Yun H.R., et al. Radiologic changes of cervical spine in ankylosing spondylitis. Clin Rheumatol 20 (2001) 262-266
4. Cerrahglu L., and Unlu M. Lumbar stiffness but not thoracic radiographic changes relate to alteration of lung function test in AS. Clin Rheumatol 21 (2002) 275-279
5. Zink A., Braun J., Listing J., et al. Disability and handicap in rheumatoid arthritis and ankylosing spondylitis - results from the German rheumatological database. German Collaborative Arthritis Centers. J Rheumatol 27 (2000) 613-622
6. Zochling J., van der Heijde D., Burgos Vargas R., et al. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 65 (2006) 442-452
7. Gorman J.D., Sack K.E., and Davis Jr. J.C. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med 346 (2002) 1349-1356
8. Davis Jr. J.C., van der Heijde D., Braun J., et al. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum 48 (2003) 3230-3236
9. Brandt J., Khariouzov A., Listing J., et al. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis. Arthritis Rheum 48 (2003) 1667-1675
10. Calin A., Dijkmans B.A., Emery P., et al. Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis. Ann Rheum Dis 63 (2004) 1594-1600
11. Braun J., Brandt J., Listing J., et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 359 (2002) 1187-1193
12. van der Heijde D., Dijkmans B., Geusens P., et al. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized controlled trial (ASSERT). Arthritis Rheum 52 (2005) 582-591
13. van der Heijde D., Kivitz A., Schiff M.H., et al. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 54 (2006) 2136-2146
14. Hammond A. What is the role of the occupational therapist?. Best Pract Res Clin Rheumatol 18 (2004) 491-505
15. Lubrano E., D'angelo S., Parsons W.J., et al. Effects of a combination treatment of an intensive rehabilitation program and etanercept in patients with ankylosing spondylitis: a pilot study. J Rheumatol 33 (2006) 2029-2034
16. Van der Linden S., Valkenburg H.A., and Cats A. Evalutation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 27 (1984) 361-368
17. Calin A., Garrett S., Whitelock H., et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21 (1994) 2281-2285
18. Garrett S., Jenkinson T., Kennedy L.G., et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21 (1994) 2286-2291
19. Jenkinson T.R., Mallorie P.A., Whitelock H.C., et al. Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 21 (1994) 1694-1698
20. Ware Jr. J.E., and Sheabourne C.D. The MOS36-item short form health survey (SF 36), 1. Conceptual frame-work and item selection. Med Care 30 (1992) 473-481
21. Dagfinrud H., Kvien T.K., and Hagen K. Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev 4 (2004) CD002822
22. Barlow J.H., and Barefoot J. Group education for people with arthritis. Patient Educ Couns 27 (1996) 257-267
23. Basler H.D., and Rehfisch H.P. Cognitive-behavioral therapy in patients with ankylosing spondylitis in a German self-help organization. J Psychosom Res 35 (1991) 345-354